- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
DCGI Chief Dr V G Somani tenure extended by 3 months
![DCGI Chief Dr V G Somani tenure extended by 3 months DCGI Chief Dr V G Somani tenure extended by 3 months](https://medicaldialogues.in/h-upload/2022/08/17/750x450_183520-dr-vg-somani.webp)
New Delhi: The tenure of Dr V G Somani as the Drugs Controller General of India (DCGI) has been extended by three months, according to an order issued by the Union Health Ministry.
Dr Somani was appointed DCGI for a term of three years on August 14, 2019.
"It has been decided with the approval of the competent authority, that Dr VG Somani shall continue to hold the charge of the post Drugs Controller of India under FR 49(v) for a period of three months w.e.f 16.08.2022 or until further orders, whichever is earlier," the official letter by the Ministry stated.
Read also: S Sridhar resigns as MD of Pfizer
The government had invited fresh applications for the position of the next DCGI in the month of February. The tenure of the current DCGI, VG Somani ended on August 15.
The DCGI heads the Central Drugs Standard Control Organization (CDSCO) which is responsible to ensure the quality of drug supply across the country. It also has the authority to give approval to new drugs and regulate clinical trials.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story